Clinical Trials Directory

Trials / Completed

CompletedNCT01083498

Fractional Laser as Treatment Option for Various Pigment Disorders

Ablative Fractional Laser Therapy as Treatment for Becker's Nevus; a Pilot Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Netherlands Institute for Pigment Disorders · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the use of ablative fractional laser is effective in the treatment of Becker's nevus.

Detailed description

Becker's nevus (BN) is an uncommon pigment disorder of the epidermis characterized by increased pigmentation, a slightly elevated, verrucous surface of the affected skin and sometimes hyperpigmentation. No effective treatment is available. Several laser modalities have been applied in the treatment of Becker's nevus in uncontrolled studies with varying results. Recently, fractional laser therapy was suggested as treatment option for Becker's nevus. In fractional laser therapy, microscopic columns of skin are coagulated or ablated, leaving the surrounding tissue intact, which enhances healing of the treated skin. In this study, the efficacy and safety of ablative fractional laser therapy was assessed in the treatment of Becker's nevus.

Conditions

Interventions

TypeNameDescription
DEVICEAblative fractional laser therapy10,600 nm ablative fractional laser Irradiance: 10 mJ/microbeam. Coverage: 35-45%. Number of treatment sessions: 3

Timeline

Start date
2009-03-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2010-03-09
Last updated
2010-03-09

Source: ClinicalTrials.gov record NCT01083498. Inclusion in this directory is not an endorsement.